Back |
home / stock / ocup / ocup message board
Subject | By | Source | When |
---|---|---|---|
chartguy89: RNN 0.74 Rexahn Pharmaceuticals Stock Charts $RNN Last Updated: 12/10/14 Last price: 0.7 | chartguy89 | investorshangout | 12/11/2014 9:38:39 AM |
Jake13: RNN Stock year to date has changed +47.06% percent. +5.63% in the last 30 days. $RNN Rexahn | Jake13 | investorshangout | 12/10/2014 11:20:29 AM |
chartguy89: RNN 0.75 Rexahn Pharmaceuticals Stock Charts $RNN Last Updated: 12/09/14 Last price: 0.7 | chartguy89 | investorshangout | 12/10/2014 10:51:08 AM |
Jake13: RNN Stock year to date has changed +49.02% percent. +7.04% in the last 30 days. $RNN Rexahn | Jake13 | investorshangout | 12/09/2014 2:21:40 PM |
chartguy89: RNN 0.76 Rexahn Pharmaceuticals Stock Charts $RNN Last Updated: 12/08/14 Last price: 0.7 | chartguy89 | investorshangout | 12/09/2014 1:25:21 PM |
ronb: Oh Yeah --WWweeee--- | ronb | investorshangout | 09/06/2013 5:37:21 PM |
News, Short Squeeze, Breakout and More Instantly...
Ocuphire Pharma Inc Com Company Name:
OCUP Stock Symbol:
NASDAQ Market:
Ocuphire Pharma Inc Com Website:
CEO to participate in ARVO SIG panel on oral medications for retinal diseases ZETA-1 Phase 2 clinical trial subset analysis to be presented during the ASRS 42 nd Annual Scientific Meeting FARMINGTON HILLS, Mich., July 10, 2024 (GLOBE NEWSWIRE) -- Ocuphire Pharma, Inc. (N...
FARMINGTON HILLS, Mich., June 06, 2024 (GLOBE NEWSWIRE) -- Ocuphire Pharma, Inc. (Nasdaq: OCUP) (“Ocuphire”), a clinical-stage biopharmaceutical company focused on developing small molecule therapies for the treatment of patients with retinal and refractive eye disorders, today anno...
FARMINGTON HILLS, Mich., May 10, 2024 (GLOBE NEWSWIRE) -- Ocuphire Pharma, Inc. (Nasdaq: OCUP), a clinical-stage ophthalmic biopharmaceutical company focused on developing small molecule therapies for the treatment of patients with retinal and refractive eye disorders, today announced financial r...